Center-Authored Papers

Filters: Author is Waisman, James  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
2013
2014
Adult
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Aged
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Antibodies, Monoclonal
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Antineoplastic Agents
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Breast Neoplasms
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Cancer Vaccines
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Cell Processing Core Facility
Center-Authored Paper
Clinical Research Division
Combined Modality Therapy
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Fatigue
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Female
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Headache
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Humans
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Kaplan-Meier Estimate
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Middle Aged
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Molecular Sequence Data
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Neoplasm Metastasis
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
November 2013
Pain
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract